NYU Langone Health
Dorry Segev, MD, PhD, is Professor of Surgery and Population Health and Vice Chair of Surgery at NYU Grossman School of Medicine and NYU Langone Health, and the founding director of the NYU Center for Surgical and Transplant Applied Research (C-STAR).
Dr. Segev was the first to demonstrate the survival benefit of incompatible kidney transplantation across the United States, and is responsible for the first HIV-to-HIV transplants in the United States. He was also the first to demonstrate poor immunogenicity to COVID vaccines in the immunocompromised, work for which he received a Letter of Commendation from Dr. Anthony Fauci. His NIH-funded research includes kidney exchange, desensitization, long-term donor risk, access to transplantation, expanding transplantation including HIV+ donors, racial and geographic disparities, post-transplant outcomes, COVID vaccines, and the intersection between transplantation, gerontology, and cognitive decline. With an undergraduate degree in computer science and a graduate degree in biostatistics, Dr. Segev focuses on novel statistical and mathematical methods for simulation of medical data, analysis of large healthcare datasets, and large multi-center innovative clinical trials and cohort studies.
Dr. Segev has published over 900 peer-reviewed research articles, and is ranked #1 worldwide in organ transplantation expertise and influence by ExpertScape. He is an elected member of the National Academy of Medicine, a recipient of the prestigious Global Thinker Award by Foreign Policy Magazine, and was named an Innovator of the Year by TIME Magazine. His work has directly influenced policy, including two Congressional bills (the Norwood Act for kidney exchange and the HOPE Act for HIV-to-HIV transplants), and is regularly featured in widely read media including several front-page features in the New York Times.
Dr. Segev is most inspired by his role as a mentor, having mentored over 100 graduate students, residents, and faculty, and is the only surgeon in the US funded by an NIH/NIAID Mentoring Grant.
Disclosure information not submitted.
Workshop 3: AABB/ASHI Symposium: Exploring Transplant Uncertainties/Conundrums in ABO
Tuesday, October 22, 2024
4:45 PM – 6:15 PM US PDT
ABO-Incompatible Transplantation from the Clinical Perspective
Tuesday, October 22, 2024
5:45 PM – 6:15 PM US PDT